Ekso Bionics (EKSO) Misses Q4 EPS by 11c

Ekso Bionics (NASDAQ: EKSO) reported Q4 EPS of ($0.22), $0.11 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $4.85 million versus the consensus estimate of $4.8 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Investing.com’s stocks of the week
• Schwab's May activity shows margin loans nearly double